0001676163 false 0001676163 2023-06-06 2023-06-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 6, 2023

 

SS INNOVATIONS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Florida   333-216054   47-3478854
(State or Other Jurisdiction
of Incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

1600 SE 15th Street, #512

Fort Lauderdale, Florida

   33316
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (954) 478-1410

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
None   N/A   N/A

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

As used in this Current Report on Form 8-K (this “Report”), and unless otherwise indicated, the terms “SSII,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. f/k/a Avra Medical Robotics, Inc. and its subsidiaries.

 

Item 7.01 Regulation FD Disclosure.

 

At 4:30 P.M. Eastern Time, Dr. Sudhir Srivastava, our Chairman and Chief Executive Officer will be making an online presentation to accredited investors at “The Accredited Investors Virtual Expo” conducted by The Money Show.

 

Interested persons who qualify as accredited investors (as defined in rule 501(a) under the Securities Act of 1933, as amended), who wish to view Dr. Srivastava’s presentation, may register at:

 

https://online.moneyshow.com/2023/june/accredited-virtual-expo/speakers/d758f5ce84b1486b851b6182dd7e930d/sudhir-srivastava/?scode=060115

 

In addition, attached as Exhibits 99.1 and 99.2 to this Report, respectively, are copies of the investor presentation and fact sheet to be used by Dr. Srivastava in connection with his presentation.

 

The foregoing information, including the investor presentation and fact sheet attached as Exhibits 99.1 and 99.2, as well as any information obtained by clicking on the above link to this Report, is being furnished pursuant to Item 7.01 of this Current Report and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended or incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1*   Investor Presentation
99.2*   Fact Sheet
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Furnished but not filed.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: June 6, 2023 SS INNOVATIONS INTERNATIONAL, INC.
     
  By: /s/ Sudhir Srivastava
    Sudhir Srivastava, M.D. Chairman and
Chief Executive Officer

 

 

2
 

Grafico Azioni AVRA Medical Robotics (PK) (USOTC:AVMR)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di AVRA Medical Robotics (PK)
Grafico Azioni AVRA Medical Robotics (PK) (USOTC:AVMR)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di AVRA Medical Robotics (PK)